We are seeking an experienced and highly motivated Senior Research Associate to join the Milner Therapeutics Institute (MTI) at the University of Cambridge, based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus.

As a Senior Research Associate, you will provide scientific and operational leadership to the UK-based team for the UK-ROK Collaboration on Engineering Biology and AI for Gene and Cell Therapy, an international research programme funded until March 2029. You will work closely with the Group Leader and Head of Research, to coordinate collaborative research across the University of Cambridge, Korean research organisations, industry and clinical partners.

Closing date: 27 September 2026.

Please quote reference XZ51036 on your application and in any correspondence about this vacancy.

Informal enquiries about the role are welcomed and should be directed to Namshik Han, Head of Computational Biology and Artificial Intelligence, at nh417@cam.ac.uk.

Any queries regarding the application process should be directed to Ella May Bailey, HR and Administration Coordinator, at hr@milner.cam.ac.uk.

To find out more and apply, click here.

Are you a start-up interested in bio-incubator space?

Become part of our vibrant Institute in a much sought after location on Cambridge Biomedical Campus. The Milner Therapeutics Institute has limited space for research intensive, R&D companies, working in an areas related to the Institute’s expertise (e.g. functional genomics, early target discovery, therapeutics). You will be working side by side with academics, entrepreneurs and industry scientists.

To discuss, please fill in this short form.

Bio-spark is an educational entrepreneurship programme that provides support for early-stage scientists, including but not limited to those engaged in a PhD or Postdoc. The programme runs annually from November to June.

Bio-spark provides opportunities to sample different company environments and offers mentorship that may lead to the formation of companies. If you can think beyond the usual boundaries, have an appetite for innovation, and are in search of the intellectual spark that will make a difference to human health, this is the programme for you.

To learn more and apply, visit their Bio-spark webpage.

The Milner Therapeutics Institute is part of Cambridge NeuroWorks, a three-year collaboration with the science funding agency ARIA and multiple Cambridge partners.

Cambridge NeuroWorks supports the development of breakthrough technologies, from electronic brain implants to brain-computer interfaces, designed to improve lives globally. NeuroWorks Fellowships provide funding, mentorship, and a dynamic community to drive bold innvoation in neurotechnology. The Milner Therapeutics Institute provides access to lab space and mentoring support for NeuroWorks Fellows, and brings together academic, clinical and industry partners across technology and therapeutics both in-person and online via Connect: Health Tech.

To learn more, visit Cambridge NeuroWorks.

Connect: Health Tech catalyses connections which spark collaboration at the interface between medicine and technology, tapping into Cambridge’s unique ecosystem to enable partnerships, innovation and future growth.

By strengthening interdisciplinary bridges between academia, industry and healthcare Connect: Health Tech facilitates real-world possibilities transforming innovative ideas into tangible outcomes that benefit society.

Join the community at: connect.cam.ac.uk

The Founders Growth Community is a collaborative effort between the Milner Therapeutics Institute, Babraham Research Campus, o2h group, Illumina Ventures, and Start Codon. The initiative comprises a series of workshops, masterclasses, round tables, and panel discussions, tailored for founders/CEOs in the scale-up, commercialisation, or growth phase. The focus is on exploring what comes next for founders/CEOs in terms of education, learning, and community development.

Visit the Founders Growth Community webpage.